FORCE's eXaming the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program
Strength of Science: High
Research Timeline: Post Approval
Most relevant for: Women with BRCA1 mutations who have had risk-reducing ovary removal and have never been diagnosed with breast cancer
Does hormone therapy (HT) alter the risk of breast cancer for woman carrying a BRCA1 mutation who have never been diagnosed with cancer? In this study, researchers showed that among women with
Quality of Writing: High
Research Timeline: Human Research
Most relevant for: Women experiencing vaginal symptoms from menopause
THIS INFORMATION HAS BEEN UPDATED. The FDA issued an alert in July, 2018 noting that laser or radiofrequency devices that have received FDA clearance are ONLY cleared for treating abnormal or pre-cancerous cervical or vaginal tissue and genital warts and have NOT been approved for vaginal rejuvenation. There are currently clinical trials enrolling women to study whether laser and radiofrequency devices can improve vaginal atrophy and other menopausal symptoms.
For many young breast cancer survivors and high-risk women, the side effects from early menopause after treatment and surgery can negatively impact their personal lives. This XRAYS looks at one of the many recent media articles on a laser procedure called MonaLisa Touch. The article, "Is Laser Treatment for Vaginal Atrophy Safe?" was published online in 2017 by FOX News and written by Dr. Manny Alvarez. XRAYS will discuss what this laser procedure actually is and how it may impact a young breast cancer patient’s life after treatment. (1/19/18)Read More
Strength of Science: Medium-High
Most relevant for: Women under 50 years of age who have had or are considering removing their ovaries
Removal of ovaries and fallopian tubes prevents ovarian cancer, but it may come with other health risks. Experts recommend removal of ovaries and fallopian tubes in women at high risk for ovarian cancer due to inherited mutations in BRCA or other genes linked to ovarian cancer risk. For these high-risk women the benefit of ovarian cancer prevention outweighs the risk of long-term complications. Based on a recent study, some researchers feel that for women who are not at increased risk for cancer, the risk for some chronic conditions is too high to consider removal of both ovaries. (11/1/16)Read More